MA71753A - Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble - Google Patents
Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase solubleInfo
- Publication number
- MA71753A MA71753A MA71753A MA71753A MA71753A MA 71753 A MA71753 A MA 71753A MA 71753 A MA71753 A MA 71753A MA 71753 A MA71753 A MA 71753A MA 71753 A MA71753 A MA 71753A
- Authority
- MA
- Morocco
- Prior art keywords
- intermediates
- preparation
- guanylate cyclase
- soluble guanylate
- novel processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862615678P | 2018-01-10 | 2018-01-10 | |
| PCT/CN2018/076982 WO2019161534A1 (en) | 2018-02-22 | 2018-02-22 | Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators |
| EP25174051.0A EP4570797A3 (en) | 2018-01-10 | 2019-01-10 | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA71753A true MA71753A (fr) | 2025-05-30 |
Family
ID=65279655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA71753A MA71753A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
| MA051565A MA51565A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA051565A MA51565A (fr) | 2018-01-10 | 2019-01-10 | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de la guanylate cyclase soluble |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US11274096B2 (https=) |
| EP (3) | EP4249469A3 (https=) |
| JP (2) | JP7357621B2 (https=) |
| KR (3) | KR102739727B1 (https=) |
| CN (3) | CN118221665A (https=) |
| AU (3) | AU2019206560B2 (https=) |
| BR (1) | BR112020013985A2 (https=) |
| CA (1) | CA3087943A1 (https=) |
| CL (3) | CL2020001814A1 (https=) |
| ES (1) | ES2963447T3 (https=) |
| IL (3) | IL275748B2 (https=) |
| JO (1) | JOP20200165A1 (https=) |
| MA (2) | MA71753A (https=) |
| MX (3) | MX2020007364A (https=) |
| SG (1) | SG11202006311SA (https=) |
| TW (2) | TWI888947B (https=) |
| WO (1) | WO2019140095A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109563077B (zh) | 2016-07-07 | 2026-03-10 | 赛克里翁治疗有限公司 | 用于制备可溶性鸟苷酸环化酶刺激剂的新方法 |
| MA71753A (fr) | 2018-01-10 | 2025-05-30 | Cyclerion Therapeutics, Inc. | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
| EP4640676A1 (en) * | 2022-12-21 | 2025-10-29 | Sunshine Lake Pharma Co., Ltd. | Crystal form of fluorine-substituted indazole compound and use thereof |
| AU2023412238A1 (en) * | 2022-12-21 | 2025-07-03 | Sunshine Lake Pharma Co., Ltd. | Crystal form of fluorine-substituted indazole compound and use thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR088020A1 (es) * | 2010-06-30 | 2014-05-07 | Ironwood Pharmaceuticals Inc | Compuestos heterociclicos como estimuladores de sgc |
| SI2970243T1 (sl) * | 2013-03-15 | 2020-04-30 | Cyclerion Therapeutics, Inc. | SGC stimulatorji |
| WO2015106268A1 (en) * | 2014-01-13 | 2015-07-16 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS |
| US20170291889A1 (en) | 2014-09-17 | 2017-10-12 | Ironwood Pharmaceuticals, Inc. | Pyrazole derivatives as sgc stimulators |
| KR20170055531A (ko) * | 2014-09-17 | 2017-05-19 | 아이언우드 파마슈티컬스, 인코포레이티드 | 에스지씨 자극제 |
| CA3006746C (en) * | 2015-11-30 | 2024-01-30 | Ironwood Pharmaceuticals, Inc. | Solid dispersions comprising a sgc stimulator |
| CN109563077B (zh) | 2016-07-07 | 2026-03-10 | 赛克里翁治疗有限公司 | 用于制备可溶性鸟苷酸环化酶刺激剂的新方法 |
| WO2018009602A2 (en) | 2016-07-07 | 2018-01-11 | Ironwood Pharmaceuticals, Inc. | Novel processes for preparation of soluble guanylate cyclase stimulators |
| MA71753A (fr) | 2018-01-10 | 2025-05-30 | Cyclerion Therapeutics, Inc. | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble |
-
2019
- 2019-01-10 MA MA71753A patent/MA71753A/fr unknown
- 2019-01-10 KR KR1020207022640A patent/KR102739727B1/ko active Active
- 2019-01-10 CN CN202410363184.1A patent/CN118221665A/zh active Pending
- 2019-01-10 JO JOP/2020/0165A patent/JOP20200165A1/ar unknown
- 2019-01-10 BR BR112020013985-8A patent/BR112020013985A2/pt active IP Right Grant
- 2019-01-10 TW TW112138274A patent/TWI888947B/zh active
- 2019-01-10 ES ES19703440T patent/ES2963447T3/es active Active
- 2019-01-10 CN CN202410363182.2A patent/CN118184645A/zh active Pending
- 2019-01-10 TW TW108101044A patent/TWI821237B/zh active
- 2019-01-10 US US16/961,109 patent/US11274096B2/en active Active
- 2019-01-10 EP EP23187776.2A patent/EP4249469A3/en active Pending
- 2019-01-10 IL IL275748A patent/IL275748B2/en unknown
- 2019-01-10 EP EP19703440.8A patent/EP3737679B1/en active Active
- 2019-01-10 EP EP25174051.0A patent/EP4570797A3/en active Pending
- 2019-01-10 MX MX2020007364A patent/MX2020007364A/es unknown
- 2019-01-10 CA CA3087943A patent/CA3087943A1/en active Pending
- 2019-01-10 WO PCT/US2019/013060 patent/WO2019140095A1/en not_active Ceased
- 2019-01-10 KR KR1020247039985A patent/KR20250002720A/ko active Pending
- 2019-01-10 IL IL314714A patent/IL314714A/en unknown
- 2019-01-10 SG SG11202006311SA patent/SG11202006311SA/en unknown
- 2019-01-10 KR KR1020257010603A patent/KR20250048609A/ko active Pending
- 2019-01-10 JP JP2020538535A patent/JP7357621B2/ja active Active
- 2019-01-10 CN CN201980017700.2A patent/CN111902410B/zh active Active
- 2019-01-10 IL IL319883A patent/IL319883A/en unknown
- 2019-01-10 MA MA051565A patent/MA51565A/fr unknown
- 2019-01-10 AU AU2019206560A patent/AU2019206560B2/en active Active
-
2020
- 2020-07-07 CL CL2020001814A patent/CL2020001814A1/es unknown
- 2020-07-13 MX MX2023000044A patent/MX2023000044A/es unknown
- 2020-07-13 MX MX2023000045A patent/MX2023000045A/es unknown
-
2021
- 2021-10-08 US US17/497,352 patent/US11708361B2/en active Active
-
2022
- 2022-04-08 CL CL2022000907A patent/CL2022000907A1/es unknown
- 2022-04-08 CL CL2022000904A patent/CL2022000904A1/es unknown
-
2023
- 2023-04-28 US US18/140,966 patent/US12030874B2/en active Active
- 2023-09-26 JP JP2023162922A patent/JP7744955B2/ja active Active
- 2023-11-22 AU AU2023270260A patent/AU2023270260B2/en active Active
-
2024
- 2024-05-22 US US18/671,182 patent/US12275724B2/en active Active
-
2025
- 2025-03-31 AU AU2025202281A patent/AU2025202281A1/en active Pending
- 2025-04-11 US US19/176,742 patent/US20250361228A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3504196A4 (en) | METHOD FOR PRODUCING OLAPARIB | |
| EP3402787A4 (en) | PROCESS FOR THE PREPARATION OF 2,5-FURANDIC ACETIC ACID AND INTERMEDIATES AND DERIVATIVES THEREOF | |
| MA55082A (fr) | Compositions, procédés, et kits pour l'administration de polyribonucléotides | |
| EP3749769A4 (en) | PROCESS FOR THE PREPARATION OF MORPHINE ALKALOIDS AND DERIVATIVES | |
| EP3893655A4 (en) | METHOD OF PREPARING A PLANT PROTEIN COMPOSITION | |
| MA46479A (fr) | Procédés et intermédiaires pour la préparation de nouveaux composés substitués de 6,7-dihydro-5h-benzo[7]annulène | |
| MA46240A (fr) | Compositions d'arn de haute pureté et procédés pour leur préparation | |
| EP3315512A4 (en) | METHOD FOR SELECTIVELY PREPARING AN ANTIBODY-ACTIVE CONJUGATE | |
| MA71753A (fr) | Nouveaux procédés et intermédiaires pour la préparation de stimulateurs de guanylate cyclase soluble | |
| EP3635022A4 (en) | Process for the preparation of functionalized fluorinated monomers, fluorinated monomers and compositions for the preparation thereof | |
| MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
| EP3294865A4 (en) | PROCESS FOR THE PREPARATION OF EPIMERASES AND BENZYLISOCHINOLINAL KALOIDES | |
| EP3529232A4 (fr) | Dérivés d'acide sulfamique et procédés pour leur préparation | |
| EP3645049A4 (en) | MULTISPECIFIC ANTIBODIES AND THE METHOD OF MANUFACTURING AND USING THEREOF | |
| EP3675847A4 (en) | SPIROCYCLUS COMPOUNDS AND METHOD OF MANUFACTURING AND USING THEREOF | |
| EP3488018A4 (en) | METHOD AND COMPOSITIONS FOR PROTEIN IDENTIFICATION | |
| EP3897717A4 (en) | Methods of producing heterodimeric antibodies | |
| MA53391A (fr) | Compositions pour l'agriculture et procédés associés | |
| EP3720456A4 (en) | IMPROVED ENRICHMENT PROCEDURES FOR THE PREPARATION OF TANNING ACID COMPOSITIONS | |
| EP3466280A4 (en) | METHOD FOR PRODUCING PROCESSED FOOD AND PROCESSED FOOD PRODUCED BY THIS | |
| MA51307A (fr) | Compositions laitières fermentées et procédés de préparation de celles-ci | |
| EP3645548A4 (en) | METHOD FOR PRODUCING BALIC ACIDS | |
| EP3803416A4 (en) | COMPOSITIONS AND METHODS FOR DETECTING BRAIN TRAUMA | |
| IL263994B (en) | Novel processes for preparation of soluble guanylate cyclase stimulators | |
| EP3314001A4 (en) | METHOD AND COMPOSITIONS FOR PREPARING EPHEDRINE AND ASSOCIATED ALKALOID COMPOUNDS |